Guo, J., Jin, D., Wu, Y., Yang, L., Du, J., Gong, K., . . . Xi, S. (2018). The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells. EBioMedicine.
Chicago-stil citatGuo, Jiwei, et al. "The MiR 495-UBE2C-ABCG2/ERCC1 Axis Reverses Cisplatin Resistance By Downregulating Drug Resistance Genes in Cisplatin-resistant Non-small Cell Lung Cancer Cells." EBioMedicine 2018.
MLA-referensGuo, Jiwei, et al. "The MiR 495-UBE2C-ABCG2/ERCC1 Axis Reverses Cisplatin Resistance By Downregulating Drug Resistance Genes in Cisplatin-resistant Non-small Cell Lung Cancer Cells." EBioMedicine 2018.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.